151 related articles for article (PubMed ID: 35378127)
21. Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.
Pocai A; Carrington PE; Adams JR; Wright M; Eiermann G; Zhu L; Du X; Petrov A; Lassman ME; Jiang G; Liu F; Miller C; Tota LM; Zhou G; Zhang X; Sountis MM; Santoprete A; Capito' E; Chicchi GG; Thornberry N; Bianchi E; Pessi A; Marsh DJ; SinhaRoy R
Diabetes; 2009 Oct; 58(10):2258-66. PubMed ID: 19602537
[TBL] [Abstract][Full Text] [Related]
22. Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases.
Lee YS; Jun HS
Int J Med Sci; 2018; 15(6):603-609. PubMed ID: 29725251
[TBL] [Abstract][Full Text] [Related]
23. Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.
Maida A; Hansotia T; Longuet C; Seino Y; Drucker DJ
Gastroenterology; 2009 Dec; 137(6):2146-57. PubMed ID: 19766644
[TBL] [Abstract][Full Text] [Related]
24. The MafA-target gene PPP1R1A regulates GLP1R-mediated amplification of glucose-stimulated insulin secretion in β-cells.
Cataldo LR; Vishnu N; Singh T; Bertonnier-Brouty L; Bsharat S; Luan C; Renström E; Prasad RB; Fex M; Mulder H; Artner I
Metabolism; 2021 May; 118():154734. PubMed ID: 33631146
[TBL] [Abstract][Full Text] [Related]
25. Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic condition.
Streckel E; Braun-Reichhart C; Herbach N; Dahlhoff M; Kessler B; Blutke A; Bähr A; Übel N; Eddicks M; Ritzmann M; Krebs S; Göke B; Blum H; Wanke R; Wolf E; Renner S
J Transl Med; 2015 Feb; 13():73. PubMed ID: 25890210
[TBL] [Abstract][Full Text] [Related]
26. Exendin-4 stimulates islet cell replication via the IGF1 receptor activation of mTORC1/S6K1.
Xie J; El Sayed NM; Qi C; Zhao X; Moore CE; Herbert TP
J Mol Endocrinol; 2014 Aug; 53(1):105-15. PubMed ID: 24994913
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
28. Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.
Wei T; Cui X; Jiang Y; Wang K; Wang D; Li F; Lin X; Gu L; Yang K; Yang J; Hong T; Wei R
Diabetes; 2023 May; 72(5):599-610. PubMed ID: 36826938
[TBL] [Abstract][Full Text] [Related]
29. AWRK6, a Novel GLP-1 Receptor Agonist, Attenuates Diabetes by Stimulating Insulin Secretion.
Wang Q; Zhao C; Jin L; Zhang H; Miao Q; Liu H; Zhang D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301245
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.
Mari A; Del Prato S; Ludvik B; Milicevic Z; de la Peña A; Shurzinske L; Karanikas CA; Pechtner V
Diabetes Obes Metab; 2016 Aug; 18(8):834-9. PubMed ID: 27059816
[TBL] [Abstract][Full Text] [Related]
31. Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction.
McLean BA; Wong CK; Kabir MG; Drucker DJ
Mol Metab; 2022 Dec; 66():101641. PubMed ID: 36396031
[TBL] [Abstract][Full Text] [Related]
32. Beneficial metabolic effects of recurrent periods of beta-cell rest and stimulation using stable neuropeptide Y1 and glucagon-like peptide-1 receptor agonists.
Tanday N; Lafferty RA; Flatt PR; Irwin N
Diabetes Obes Metab; 2022 Dec; 24(12):2353-2363. PubMed ID: 35848461
[TBL] [Abstract][Full Text] [Related]
33. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
34. GPR119 agonists 2009-2011.
Buzard DJ; Lehmann J; Han S; Jones RM
Pharm Pat Anal; 2012 Jul; 1(3):285-99. PubMed ID: 24236842
[TBL] [Abstract][Full Text] [Related]
35. Effects of boschnaloside from Boschniakia rossica on dysglycemia and islet dysfunction in severely diabetic mice through modulating the action of glucagon-like peptide-1.
Lin LC; Lee LC; Huang C; Chen CT; Song JS; Shiao YJ; Liu HK
Phytomedicine; 2019 Sep; 62():152946. PubMed ID: 31102890
[TBL] [Abstract][Full Text] [Related]
36. Chronic Suppression of Glucagon-Like Peptide-1 Receptor (GLP1R) mRNA Translation in the Rat Bed Nucleus of the Stria Terminalis Reduces Anxiety-Like Behavior and Stress-Induced Hypophagia, But Prolongs Stress-Induced Elevation of Plasma Corticosterone.
Zheng H; Reiner DJ; Hayes MR; Rinaman L
J Neurosci; 2019 Apr; 39(14):2649-2663. PubMed ID: 30683681
[TBL] [Abstract][Full Text] [Related]
37. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
Maida A; Lovshin JA; Baggio LL; Drucker DJ
Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
[TBL] [Abstract][Full Text] [Related]
38. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.
Masson E; Koren S; Razik F; Goldberg H; Kwan EP; Sheu L; Gaisano HY; Fantus IG
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1251-61. PubMed ID: 19223654
[TBL] [Abstract][Full Text] [Related]
39. Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass.
Meier JJ; Ueberberg S; Korbas S; Schneider S
Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E717-23. PubMed ID: 21285404
[TBL] [Abstract][Full Text] [Related]
40. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice.
Maida A; Lamont BJ; Cao X; Drucker DJ
Diabetologia; 2011 Feb; 54(2):339-49. PubMed ID: 20972533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
